Patented Medicines (Notice of Compliance) Regulations, SOR/93-133

Section 4.1

Cite as Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, s. 4.1 · current to July 24, 2025 · regulation last amended January 1, 2025

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) In this section, supplement to the new drug submission means a supplement to a new drug submission or a supplement to an extraordinary use new drug submission as those terms are used in Division 8 of Part C of the Food and Drug Regulations. (2) A first person who submits a patent list in relation to a new drug submission referred to in subsection 4(2) may, if the list is added to the register, resubmit the same list in relation to a supplement to the new drug submission, but may not submit a new patent list in relation to a supplement except in accordance with subsection 4(3).
Read the Patented Medicines (Notice of Compliance) Regulations on the Justice Laws Website ↗

Made under Patent Act, R.S.C. 1985, c. P-4.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.